Literature DB >> 28666849

The indications of tautomeric conversion in amorphous bicalutamide drug.

Marzena Rams-Baron1, Patryk Wlodarczyk2, Mateusz Dulski3, Agnieszka Wlodarczyk4, Danuta Kruk5, Adam Rachocki6, Renata Jachowicz7, Marian Paluch8.   

Abstract

Entities:  

Keywords:  Amorphous bicalutamide; DFT calculation; Dielectric spectroscopy; Proton transfer reaction; Tautomerization

Mesh：

Substances：

Year:  2017        PMID： 28666849     DOI： 10.1016/j.ejps.2017.06.034

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN： 0928-0987            Impact factor:   4.384


× No keyword cloud information.
  3 in total

1.  Compression-Induced Phase Transitions of Bicalutamide.

Authors:  Joanna Szafraniec-Szczęsny; Agata Antosik-Rogóż; Justyna Knapik-Kowalczuk; Mateusz Kurek; Ewa Szefer; Karolina Gawlak; Krzysztof Chmiel; Sebastian Peralta; Krzysztof Niwiński; Krzysztof Pielichowski; Marian Paluch; Renata Jachowicz
Journal:  Pharmaceutics       Date:  2020-05-09       Impact factor: 6.321

2.  Molecular Disorder of Bicalutamide-Amorphous Solid Dispersions Obtained by Solvent Methods.

Authors:  Joanna Szafraniec; Agata Antosik; Justyna Knapik-Kowalczuk; Karolina Gawlak; Mateusz Kurek; Jakub Szlęk; Witold Jamróz; Marian Paluch; Renata Jachowicz
Journal:  Pharmaceutics       Date:  2018-10-18       Impact factor: 6.321

3.  Data-Driven Modeling of the Bicalutamide Dissolution from Powder Systems.

Authors:  Aleksander Mendyk; Adam Pacławski; Joanna Szafraniec-Szczęsny; Agata Antosik; Witold Jamróz; Marian Paluch; Renata Jachowicz
Journal:  AAPS PharmSciTech       Date:  2020-03-31       Impact factor: 3.246
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.